SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jonathan Schonsheck who wrote (4059)1/13/1999 9:19:00 PM
From: Hank  Read Replies (1) of 4342
 
People,

While the news of the Roswell trials is extremely encouraging, I will re-emphasize a point I made many moons ago. PRLN needs a major pharmaceutical company as a partner when it comes to the development of potential drug candidates. The inevitable clinical trials that will have to be conducted will cost mucho denaro and PRLN doesn't have it. I suspect the in vivo mice trials that will be concluded this spring will give PRLN the data they need to get this kind of support, assuming the results are positive. Unfortunately, everybody frowns on a penny stock in a shaky market environment, so don't expect the price to triple any time soon. However, the results do warrant watching the market activity in PRLN very closely. I am not back into the fold just just yet but this announcement makes me think I will be very soon.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext